aTYR PHARMA INC - ATYR

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$48.92M
QoQ value delta ($000)
-$7.607M (-13.46%)
Implied price effect (QoQ)
-22.9%
Shares
Total shares
62,758,705
QoQ shares delta
+6,847,356 (+12.25%)
Total shares held by funds (by quarter)

Market chart (ATYR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 113 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
FMR LLC 11,471 14,706,843 0.0%
FEDERATED HERMES, INC. 8,197 10,509,678 0.01%
BlackRock, Inc. 5,026 6,443,904 0.0%
VANGUARD GROUP INC 3,885 4,961,871 0.0%
UBS Group AG 3,016 3,867,213 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 2,973 3,812,132 0.0%
GEODE CAPITAL MANAGEMENT, LLC 1,861 2,385,485 0.0%
STATE STREET CORP 1,368 1,754,399 0.0%
GSA CAPITAL PARTNERS LLP 1,314 1,684,586 0.08%
MILLENNIUM MANAGEMENT LLC 1,280 1,641,246 0.0%
MORGAN STANLEY 955 1,225,467 0.0%
TWO SIGMA INVESTMENTS, LP 892 1,144,565 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 883 1,132,344 0.0%
TWO SIGMA ADVISERS, LP 658 841,350 0.0%
NORTHERN TRUST CORP 554 711,105 0.0%
VANGUARD FIDUCIARY TRUST CO 508 651,832 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 443 569,227 0.0%
JANE STREET GROUP, LLC 391 501,402 0.0%
AQR CAPITAL MANAGEMENT LLC 386 496,018 0.0%
BANK OF AMERICA CORP /DE/ 236 303,559 0.0%
GOLDMAN SACHS GROUP INC 220 283,236 0.0%
Nuveen, LLC 178 229,284 0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 164 210,737 0.0%
CITADEL ADVISORS LLC 158 203,372 0.0%
Bank of New York Mellon Corp 150 193,531 0.0%